Direct-to-consumer genetic testing: summary of a workshop
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C.
National Academies Press
c2011
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Includes bibliographical references Introduction -- - Scientific foundations for direct-to-consumer genetic testing -- - Personal and social issues -- - Research and medical issues -- - Impact on health care and public health -- - Current legislative and regulatory framework in the United States -- - Areas for further study "Today, scores of companies, primarily in the United States and Europe, are offering whole genome scanning services directly to the public. The proliferation of these companies and the services they offer demonstrate a public appetite for this information and where the future of genetics may be headed; they also demonstrate the need for serious discussion about the regulatory environment, patient privacy, and other policy implications of direct-to-consumer (DTC) genetic testing. Rapid advances in genetic research already have begun to transform clinical practice and our understanding of disease progression. Existing research has revealed a genetic basis or component for numerous diseases, including Parkinson's disease, Alzheimer's disease, diabetes, heart disease, and several forms of cancer. The availability of the human genome sequence and the HapMap, plummeting costs of high-throughput screening, and increasingly sophisticated computational analyses have led to an explosion of discoveries of linkages between patterns of genetic variation and disease susceptibility. While this research is by no means a straight path toward better public health, improved knowledge of the genetic linkages has the potential to change fundamentally the way health professionals and public health practitioners approach the prevention and treatment of disease. Realizing this potential will require greater sophistication in the interpretation of genetic tests, new training for physicians and other diagnosticians, and new approaches to communicating findings to the public. As this rapidly growing field matures, all of these questions require attention from a variety of perspectives. To discuss some of the foregoing issues, several units of the National Academies held a workshop on August 31 and September 1, 2009, to bring together a still-developing community of professionals from a variety of relevant disciplines, to educate the public and policy-makers about this emerging field, and to identify issues for future study. The meeting featured several invited presentations and discussions on the many technical, legal, policy, and ethical questions that such DTC testing raises, including: (1) overview of the current state of knowledge and the future research trajectory; (2) shared genes and emerging issues in privacy; (3) the regulatory framework; and (4) education of the public and the medical community."--Publisher's description |
| Beschreibung: | 1 Online-Ressource (xii, 93 p.) |
| ISBN: | 0309162165 0309162173 9780309162166 9780309162173 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043164223 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2011 |||| o||u| ||||||eng d | ||
| 020 | |a 0309162165 |9 0-309-16216-5 | ||
| 020 | |a 0309162173 |c electronic bk. |9 0-309-16217-3 | ||
| 020 | |a 9780309162166 |9 978-0-309-16216-6 | ||
| 020 | |a 9780309162173 |c electronic bk. |9 978-0-309-16217-3 | ||
| 035 | |a (OCoLC)703255596 | ||
| 035 | |a (DE-599)BVBBV043164223 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 616.042 |2 22 | |
| 110 | 2 | |a National Research Council (U.S.) |b Committee on Science, Technology, and Law |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Direct-to-consumer genetic testing |b summary of a workshop |c Mary Fraker and Anne-Marie Mazza, rapporteurs ; Committee on Science, Technology, and Law Policy and Global Affairs, Board on Life Sciences ... [et al.], Institute of Medicine and National Research Council of the National Academies |
| 264 | 1 | |a Washington, D.C. |b National Academies Press |c c2011 | |
| 300 | |a 1 Online-Ressource (xii, 93 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references | ||
| 500 | |a Introduction -- - Scientific foundations for direct-to-consumer genetic testing -- - Personal and social issues -- - Research and medical issues -- - Impact on health care and public health -- - Current legislative and regulatory framework in the United States -- - Areas for further study | ||
| 500 | |a "Today, scores of companies, primarily in the United States and Europe, are offering whole genome scanning services directly to the public. The proliferation of these companies and the services they offer demonstrate a public appetite for this information and where the future of genetics may be headed; they also demonstrate the need for serious discussion about the regulatory environment, patient privacy, and other policy implications of direct-to-consumer (DTC) genetic testing. Rapid advances in genetic research already have begun to transform clinical practice and our understanding of disease progression. Existing research has revealed a genetic basis or component for numerous diseases, including Parkinson's disease, Alzheimer's disease, diabetes, heart disease, and several forms of cancer. | ||
| 500 | |a The availability of the human genome sequence and the HapMap, plummeting costs of high-throughput screening, and increasingly sophisticated computational analyses have led to an explosion of discoveries of linkages between patterns of genetic variation and disease susceptibility. While this research is by no means a straight path toward better public health, improved knowledge of the genetic linkages has the potential to change fundamentally the way health professionals and public health practitioners approach the prevention and treatment of disease. Realizing this potential will require greater sophistication in the interpretation of genetic tests, new training for physicians and other diagnosticians, and new approaches to communicating findings to the public. As this rapidly growing field matures, all of these questions require attention from a variety of perspectives. | ||
| 500 | |a To discuss some of the foregoing issues, several units of the National Academies held a workshop on August 31 and September 1, 2009, to bring together a still-developing community of professionals from a variety of relevant disciplines, to educate the public and policy-makers about this emerging field, and to identify issues for future study. The meeting featured several invited presentations and discussions on the many technical, legal, policy, and ethical questions that such DTC testing raises, including: (1) overview of the current state of knowledge and the future research trajectory; (2) shared genes and emerging issues in privacy; (3) the regulatory framework; and (4) education of the public and the medical community."--Publisher's description | ||
| 650 | 4 | |a Genetic Testing / Congresses | |
| 650 | 4 | |a Genetic Predisposition to Disease / Congresses | |
| 650 | 4 | |a Marketing of Health Services / Congresses | |
| 650 | 4 | |a Self Care / Congresses | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / Genetic |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Genetics |2 bisacsh | |
| 650 | 7 | |a Human chromosome abnormalities / Diagnosis |2 fast | |
| 650 | 7 | |a Self-examination, Medical |2 fast | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Human chromosome abnormalities |x Diagnosis |v Congresses | |
| 650 | 4 | |a Self-examination, Medical |v Congresses | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 700 | 1 | |a Fraker, Mary |e Sonstige |4 oth | |
| 700 | 1 | |a Mazza, Anne-Marie |e Sonstige |4 oth | |
| 710 | 2 | |a National Research Council (U.S.) |b Board on Life Sciences |e Sonstige |4 oth | |
| 710 | 2 | |a Institute of Medicine (U.S.) |b Forum on Drug Discovery, Development, and Translation |e Sonstige |4 oth | |
| 710 | 2 | |a Institute of Medicine (U.S.) |b Roundtable on Translating Genomic-Based Research for Health |e Sonstige |4 oth | |
| 710 | 2 | |a National Cancer Policy Forum (U.S.) |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=350899 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028588414 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=350899 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=350899 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175637606301696 |
|---|---|
| any_adam_object | |
| author_corporate | National Research Council (U.S.) Committee on Science, Technology, and Law |
| author_corporate_role | aut |
| author_facet | National Research Council (U.S.) Committee on Science, Technology, and Law |
| author_sort | National Research Council (U.S.) Committee on Science, Technology, and Law |
| building | Verbundindex |
| bvnumber | BV043164223 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)703255596 (DE-599)BVBBV043164223 |
| dewey-full | 616.042 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.042 |
| dewey-search | 616.042 |
| dewey-sort | 3616.042 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05703nmm a2200625zc 4500</leader><controlfield tag="001">BV043164223</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2011 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309162165</subfield><subfield code="9">0-309-16216-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309162173</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-309-16217-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309162166</subfield><subfield code="9">978-0-309-16216-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309162173</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-309-16217-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)703255596</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043164223</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.042</subfield><subfield code="2">22</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">National Research Council (U.S.)</subfield><subfield code="b">Committee on Science, Technology, and Law</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Direct-to-consumer genetic testing</subfield><subfield code="b">summary of a workshop</subfield><subfield code="c">Mary Fraker and Anne-Marie Mazza, rapporteurs ; Committee on Science, Technology, and Law Policy and Global Affairs, Board on Life Sciences ... [et al.], Institute of Medicine and National Research Council of the National Academies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">c2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xii, 93 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Introduction -- - Scientific foundations for direct-to-consumer genetic testing -- - Personal and social issues -- - Research and medical issues -- - Impact on health care and public health -- - Current legislative and regulatory framework in the United States -- - Areas for further study</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"Today, scores of companies, primarily in the United States and Europe, are offering whole genome scanning services directly to the public. The proliferation of these companies and the services they offer demonstrate a public appetite for this information and where the future of genetics may be headed; they also demonstrate the need for serious discussion about the regulatory environment, patient privacy, and other policy implications of direct-to-consumer (DTC) genetic testing. Rapid advances in genetic research already have begun to transform clinical practice and our understanding of disease progression. Existing research has revealed a genetic basis or component for numerous diseases, including Parkinson's disease, Alzheimer's disease, diabetes, heart disease, and several forms of cancer. </subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">The availability of the human genome sequence and the HapMap, plummeting costs of high-throughput screening, and increasingly sophisticated computational analyses have led to an explosion of discoveries of linkages between patterns of genetic variation and disease susceptibility. While this research is by no means a straight path toward better public health, improved knowledge of the genetic linkages has the potential to change fundamentally the way health professionals and public health practitioners approach the prevention and treatment of disease. Realizing this potential will require greater sophistication in the interpretation of genetic tests, new training for physicians and other diagnosticians, and new approaches to communicating findings to the public. As this rapidly growing field matures, all of these questions require attention from a variety of perspectives. </subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">To discuss some of the foregoing issues, several units of the National Academies held a workshop on August 31 and September 1, 2009, to bring together a still-developing community of professionals from a variety of relevant disciplines, to educate the public and policy-makers about this emerging field, and to identify issues for future study. The meeting featured several invited presentations and discussions on the many technical, legal, policy, and ethical questions that such DTC testing raises, including: (1) overview of the current state of knowledge and the future research trajectory; (2) shared genes and emerging issues in privacy; (3) the regulatory framework; and (4) education of the public and the medical community."--Publisher's description</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genetic Testing / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genetic Predisposition to Disease / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Marketing of Health Services / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Self Care / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Genetic</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Genetics</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Human chromosome abnormalities / Diagnosis</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Self-examination, Medical</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human chromosome abnormalities</subfield><subfield code="x">Diagnosis</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Self-examination, Medical</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fraker, Mary</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mazza, Anne-Marie</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Research Council (U.S.)</subfield><subfield code="b">Board on Life Sciences</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Forum on Drug Discovery, Development, and Translation</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Roundtable on Translating Genomic-Based Research for Health</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Cancer Policy Forum (U.S.)</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=350899</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028588414</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=350899</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=350899</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV043164223 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:19:27Z |
| institution | BVB |
| isbn | 0309162165 0309162173 9780309162166 9780309162173 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028588414 |
| oclc_num | 703255596 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xii, 93 p.) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | National Academies Press |
| record_format | marc |
| spelling | National Research Council (U.S.) Committee on Science, Technology, and Law Verfasser aut Direct-to-consumer genetic testing summary of a workshop Mary Fraker and Anne-Marie Mazza, rapporteurs ; Committee on Science, Technology, and Law Policy and Global Affairs, Board on Life Sciences ... [et al.], Institute of Medicine and National Research Council of the National Academies Washington, D.C. National Academies Press c2011 1 Online-Ressource (xii, 93 p.) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references Introduction -- - Scientific foundations for direct-to-consumer genetic testing -- - Personal and social issues -- - Research and medical issues -- - Impact on health care and public health -- - Current legislative and regulatory framework in the United States -- - Areas for further study "Today, scores of companies, primarily in the United States and Europe, are offering whole genome scanning services directly to the public. The proliferation of these companies and the services they offer demonstrate a public appetite for this information and where the future of genetics may be headed; they also demonstrate the need for serious discussion about the regulatory environment, patient privacy, and other policy implications of direct-to-consumer (DTC) genetic testing. Rapid advances in genetic research already have begun to transform clinical practice and our understanding of disease progression. Existing research has revealed a genetic basis or component for numerous diseases, including Parkinson's disease, Alzheimer's disease, diabetes, heart disease, and several forms of cancer. The availability of the human genome sequence and the HapMap, plummeting costs of high-throughput screening, and increasingly sophisticated computational analyses have led to an explosion of discoveries of linkages between patterns of genetic variation and disease susceptibility. While this research is by no means a straight path toward better public health, improved knowledge of the genetic linkages has the potential to change fundamentally the way health professionals and public health practitioners approach the prevention and treatment of disease. Realizing this potential will require greater sophistication in the interpretation of genetic tests, new training for physicians and other diagnosticians, and new approaches to communicating findings to the public. As this rapidly growing field matures, all of these questions require attention from a variety of perspectives. To discuss some of the foregoing issues, several units of the National Academies held a workshop on August 31 and September 1, 2009, to bring together a still-developing community of professionals from a variety of relevant disciplines, to educate the public and policy-makers about this emerging field, and to identify issues for future study. The meeting featured several invited presentations and discussions on the many technical, legal, policy, and ethical questions that such DTC testing raises, including: (1) overview of the current state of knowledge and the future research trajectory; (2) shared genes and emerging issues in privacy; (3) the regulatory framework; and (4) education of the public and the medical community."--Publisher's description Genetic Testing / Congresses Genetic Predisposition to Disease / Congresses Marketing of Health Services / Congresses Self Care / Congresses HEALTH & FITNESS / Diseases / Genetic bisacsh MEDICAL / Genetics bisacsh Human chromosome abnormalities / Diagnosis fast Self-examination, Medical fast Medizin Human chromosome abnormalities Diagnosis Congresses Self-examination, Medical Congresses (DE-588)1071861417 Konferenzschrift gnd-content Fraker, Mary Sonstige oth Mazza, Anne-Marie Sonstige oth National Research Council (U.S.) Board on Life Sciences Sonstige oth Institute of Medicine (U.S.) Forum on Drug Discovery, Development, and Translation Sonstige oth Institute of Medicine (U.S.) Roundtable on Translating Genomic-Based Research for Health Sonstige oth National Cancer Policy Forum (U.S.) Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=350899 Aggregator Volltext |
| spellingShingle | Direct-to-consumer genetic testing summary of a workshop Genetic Testing / Congresses Genetic Predisposition to Disease / Congresses Marketing of Health Services / Congresses Self Care / Congresses HEALTH & FITNESS / Diseases / Genetic bisacsh MEDICAL / Genetics bisacsh Human chromosome abnormalities / Diagnosis fast Self-examination, Medical fast Medizin Human chromosome abnormalities Diagnosis Congresses Self-examination, Medical Congresses |
| subject_GND | (DE-588)1071861417 |
| title | Direct-to-consumer genetic testing summary of a workshop |
| title_auth | Direct-to-consumer genetic testing summary of a workshop |
| title_exact_search | Direct-to-consumer genetic testing summary of a workshop |
| title_full | Direct-to-consumer genetic testing summary of a workshop Mary Fraker and Anne-Marie Mazza, rapporteurs ; Committee on Science, Technology, and Law Policy and Global Affairs, Board on Life Sciences ... [et al.], Institute of Medicine and National Research Council of the National Academies |
| title_fullStr | Direct-to-consumer genetic testing summary of a workshop Mary Fraker and Anne-Marie Mazza, rapporteurs ; Committee on Science, Technology, and Law Policy and Global Affairs, Board on Life Sciences ... [et al.], Institute of Medicine and National Research Council of the National Academies |
| title_full_unstemmed | Direct-to-consumer genetic testing summary of a workshop Mary Fraker and Anne-Marie Mazza, rapporteurs ; Committee on Science, Technology, and Law Policy and Global Affairs, Board on Life Sciences ... [et al.], Institute of Medicine and National Research Council of the National Academies |
| title_short | Direct-to-consumer genetic testing |
| title_sort | direct to consumer genetic testing summary of a workshop |
| title_sub | summary of a workshop |
| topic | Genetic Testing / Congresses Genetic Predisposition to Disease / Congresses Marketing of Health Services / Congresses Self Care / Congresses HEALTH & FITNESS / Diseases / Genetic bisacsh MEDICAL / Genetics bisacsh Human chromosome abnormalities / Diagnosis fast Self-examination, Medical fast Medizin Human chromosome abnormalities Diagnosis Congresses Self-examination, Medical Congresses |
| topic_facet | Genetic Testing / Congresses Genetic Predisposition to Disease / Congresses Marketing of Health Services / Congresses Self Care / Congresses HEALTH & FITNESS / Diseases / Genetic MEDICAL / Genetics Human chromosome abnormalities / Diagnosis Self-examination, Medical Medizin Human chromosome abnormalities Diagnosis Congresses Self-examination, Medical Congresses Konferenzschrift |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=350899 |
| work_keys_str_mv | AT nationalresearchcounciluscommitteeonsciencetechnologyandlaw directtoconsumergenetictestingsummaryofaworkshop AT frakermary directtoconsumergenetictestingsummaryofaworkshop AT mazzaannemarie directtoconsumergenetictestingsummaryofaworkshop AT nationalresearchcouncilusboardonlifesciences directtoconsumergenetictestingsummaryofaworkshop AT instituteofmedicineusforumondrugdiscoverydevelopmentandtranslation directtoconsumergenetictestingsummaryofaworkshop AT instituteofmedicineusroundtableontranslatinggenomicbasedresearchforhealth directtoconsumergenetictestingsummaryofaworkshop AT nationalcancerpolicyforumus directtoconsumergenetictestingsummaryofaworkshop |